Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment
Roy van der Meel(Eindhoven University of Technology), Robbert J. Kok(Utrecht University), Wim E. Hennink(Utrecht University), Raymond M. Schiffelers(University Medical Center Utrecht), Rob C. Roovers(Utrecht University), Joris van der Veeken(Utrecht University), Gert Storm(Yong In University), Işıl Altıntaş(Genmab (Netherlands)), Rob Haselberg(Utrecht University), Sabrina Oliveira(Unknown), Paul M.P. van Bergen en Henegouwen(Utrecht University)
Cited by 105
Related Papers
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
The current landscape of nucleic acid therapeutics
|Nature Nanotechnology|2021|1.3k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k